• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mortality rates are increased in patients with systemic juvenile idiopathic arthritis.

作者信息

Davies Rebecca, Southwood Taunton, Kearsley-Fleet Lianne, Lunt Mark, Baildam Eileen, Beresford Michael W, Foster Helen E, Douglas Sharon, Thomson Wendy, De Cock Diederik, Hyrich Kimme L

机构信息

Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.

Institute of Child Health, University of Birmingham and Birmingham Children's Hospital, Birmingham, UK.

出版信息

Arch Dis Child. 2017 Feb;102(2):206-207. doi: 10.1136/archdischild-2016-311571. Epub 2016 Oct 31.

DOI:10.1136/archdischild-2016-311571
PMID:27799155
Abstract
摘要

相似文献

1
Mortality rates are increased in patients with systemic juvenile idiopathic arthritis.全身型幼年特发性关节炎患者的死亡率会升高。
Arch Dis Child. 2017 Feb;102(2):206-207. doi: 10.1136/archdischild-2016-311571. Epub 2016 Oct 31.
2
Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry.幼年特发性关节炎患者使用阿达木单抗、依那西普和甲氨蝶呤治疗期间的葡萄膜炎事件：来自儿科风湿病登记处生物制剂的数据。
Arthritis Care Res (Hoboken). 2015 Nov;67(11):1529-35. doi: 10.1002/acr.22613.
3
Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach.青少年特发性关节炎患者的临床缓解及随后的复发：根据治疗方法的预测因素。
Pediatr Rheumatol Online J. 2021 Aug 21;19(1):130. doi: 10.1186/s12969-021-00607-0.
4
Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).系统性幼年特发性关节炎初始治疗四种共识治疗方案的贝叶斯比较有效性研究：系统性幼年特发性关节炎治疗的一线选择（FROST）
Clin Trials. 2018 Jun;15(3):268-277. doi: 10.1177/1740774518761367. Epub 2018 Mar 15.
5
Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience.全身型幼年特发性关节炎患者的预后、并发症和治疗反应：单中心经验。
Int J Rheum Dis. 2019 Sep;22(9):1661-1669. doi: 10.1111/1756-185X.13649. Epub 2019 Jul 4.
6
[Diagnosis and treatment of juvenile idiopathic arthritis (JIA)].青少年特发性关节炎（JIA）的诊断与治疗
Nihon Rinsho. 2016 Jun;74(6):1028-34.
7
Strategies for the prevention and management of methotrexate-related nausea and vomiting in juvenile idiopathic arthritis: results of a UK Paediatric Rheumatology prescriber survey.青少年特发性关节炎中与甲氨蝶呤相关的恶心和呕吐的预防及管理策略：英国儿科风湿病学处方者调查结果
Rheumatology (Oxford). 2015 Nov;54(11):2108-9. doi: 10.1093/rheumatology/kev259. Epub 2015 Jul 23.
8
[Not Available].[无可用内容]
Drug Res (Stuttg). 2018 Nov;68(S 01):S8-S9. doi: 10.1055/a-0733-0783. Epub 2018 Nov 19.
9
An update on the safety of biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis.用于治疗多关节型幼年特发性关节炎的生物疗法安全性最新进展。
Expert Opin Drug Saf. 2025 Jun;24(6):627-642. doi: 10.1080/14740338.2025.2467179. Epub 2025 Feb 16.
10
Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry.德国儿科风湿病生物制剂登记处中与肿瘤坏死因子抑制剂及疾病活动相关的幼年特发性关节炎患者发生严重感染的风险
Arthritis Care Res (Hoboken). 2017 Apr;69(4):552-560. doi: 10.1002/acr.22961.

引用本文的文献

1
Type I interferon signature and cycling lymphocytes in macrophage activation syndrome.Ⅰ型干扰素特征与巨噬细胞活化综合征中的循环淋巴细胞。
J Clin Invest. 2023 Nov 15;133(22):e165616. doi: 10.1172/JCI165616.
2
Disease evolution in systemic juvenile idiopathic arthritis: an international, observational cohort study through JIRcohort.系统性幼年特发性关节炎的疾病演变：通过 JIRcohort 进行的国际观察性队列研究。
Pediatr Rheumatol Online J. 2023 Sep 7;21(1):96. doi: 10.1186/s12969-023-00886-9.
3
mTORC1 links pathology in experimental models of Still's disease and macrophage activation syndrome.
mTORC1 将斯蒂尔病和巨噬细胞活化综合征的实验模型中的病理学联系起来。
Nat Commun. 2022 Nov 28;13(1):6915. doi: 10.1038/s41467-022-34480-6.
4
Altered molecular pathways and prognostic markers in active systemic juvenile idiopathic arthritis: integrated bioinformatic analysis.活动性全身型幼年特发性关节炎中改变的分子通路和预后标志物：综合生物信息学分析。
Bosn J Basic Med Sci. 2022 Apr 1;22(2):247-260. doi: 10.17305/bjbms.2021.6016.
5
Emergent high fatality lung disease in systemic juvenile arthritis.全身型幼年特发性关节炎中突发的高病死率肺病。
Ann Rheum Dis. 2019 Dec;78(12):1722-1731. doi: 10.1136/annrheumdis-2019-216040. Epub 2019 Sep 27.
6
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis.全身型幼年特发性关节炎中白细胞介素-1抑制剂的药物留存率及药物生存预测因素
Front Pharmacol. 2019 Jan 8;9:1526. doi: 10.3389/fphar.2018.01526. eCollection 2018.
7
Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis.同种异体造血干细胞移植治疗严重、难治性幼年特发性关节炎。
Blood Adv. 2018 Apr 10;2(7):777-786. doi: 10.1182/bloodadvances.2017014449.